Financials Bruker Corporation

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-06-21 pm EDT 5-day change 1st Jan Change
66.02 USD -0.78% Intraday chart for Bruker Corporation +2.31% -10.15%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,849 8,288 12,725 10,053 10,170 9,991 - -
Enterprise Value (EV) 1 7,977 8,400 12,991 10,627 10,964 10,892 10,595 10,504
P/E ratio 40.5 x 53.1 x 46.4 x 34.3 x 25.3 x 31.9 x 24.5 x 17 x
Yield 0.31% 0.3% 0.19% 0.29% 0.27% 0.3% 0.3% 0.3%
Capitalization / Revenue 3.79 x 4.17 x 5.26 x 3.97 x 3.43 x 2.94 x 2.7 x 2.54 x
EV / Revenue 3.85 x 4.23 x 5.37 x 4.2 x 3.7 x 3.21 x 2.86 x 2.67 x
EV / EBITDA 19.9 x 23.2 x 24.9 x 19.1 x 17.9 x 17 x 13.8 x 11.7 x
EV / FCF 56.8 x 35.7 x 68.2 x 73.2 x 45.1 x 46.5 x 23.1 x -
FCF Yield 1.76% 2.8% 1.47% 1.37% 2.22% 2.15% 4.33% -
Price to Book 8.57 x 8.58 x 12 x 9 x - 5.57 x 4.48 x -
Nbr of stocks (in thousands) 153,992 153,108 151,655 147,083 138,411 151,336 - -
Reference price 2 50.97 54.13 83.91 68.35 73.48 66.02 66.02 66.02
Announcement Date 3/27/20 2/16/21 2/11/22 2/9/23 2/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,073 1,988 2,418 2,531 2,964 3,394 3,705 3,934
EBITDA 1 401.3 361.9 521.9 556.5 614.1 639.3 766.5 895.2
EBIT 1 364 317.2 470.2 505.6 546.3 562.3 675.8 775.5
Operating Margin 17.56% 15.96% 19.45% 19.98% 18.43% 16.57% 18.24% 19.71%
Earnings before Tax (EBT) 1 - - - - - 557.7 669.4 771.7
Net income 1 197.2 157.8 277.1 296.6 427.2 310.1 399.9 571.1
Net margin 9.51% 7.94% 11.46% 11.72% 14.41% 9.14% 10.79% 14.52%
EPS 2 1.260 1.020 1.810 1.990 2.900 2.070 2.690 3.890
Free Cash Flow 1 140.4 235 190.4 145.2 243.2 234 458.3 -
FCF margin 6.77% 11.82% 7.87% 5.74% 8.2% 6.89% 12.37% -
FCF Conversion (EBITDA) 34.99% 64.94% 36.48% 26.09% 39.6% 36.6% 59.79% -
FCF Conversion (Net income) 71.2% 148.92% 68.71% 48.95% 56.93% 75.46% 114.61% -
Dividend per Share 2 0.1600 0.1600 0.1600 0.2000 0.2000 0.2002 0.1996 0.1991
Announcement Date 3/27/20 2/16/21 2/11/22 2/9/23 2/13/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 683.5 595 588.4 638.9 708.4 685.3 681.9 742.8 854.5 721.7 794.4 876.7 1,001 839.9 880.8
EBITDA 1 156.6 128.2 110 155.3 163 153.8 118.8 163.4 178.1 119.2 131.7 169.8 214.8 169.5 163.9
EBIT 1 143.8 115.8 97.7 143.2 148.9 139.4 104.1 148.3 154.5 100.7 113.5 151.4 200.5 134.2 135.9
Operating Margin 21.04% 19.46% 16.6% 22.41% 21.02% 20.34% 15.27% 19.96% 18.08% 13.95% 14.29% 17.26% 20.04% 15.98% 15.43%
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income 1 75.7 61.6 49.5 88.1 97.4 76.5 57.1 88.1 205.5 50.9 65.8 84.6 109 - -
Net margin 11.08% 10.35% 8.41% 13.79% 13.75% 11.16% 8.37% 11.86% 24.05% 7.05% 8.28% 9.65% 10.89% - -
EPS 2 0.5000 0.4100 0.3300 0.5900 0.6600 0.5200 0.3900 0.6000 1.410 0.3500 0.4500 0.5800 0.7500 - -
Dividend per Share 2 0.0400 - - - 0.0500 0.0500 - - 0.0500 - 0.0501 0.0502 0.0502 0.0499 -
Announcement Date 2/11/22 5/4/22 8/3/22 11/3/22 2/9/23 5/4/23 8/3/23 11/2/23 2/13/24 5/2/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 128 113 266 574 793 900 604 513
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.32 x 0.3114 x 0.5097 x 1.031 x 1.292 x 1.408 x 0.7883 x 0.5725 x
Free Cash Flow 1 140 235 190 145 243 234 458 -
ROE (net income / shareholders' equity) 27% 22% 31.6% 31.9% 30.1% 24.1% 22% 16.3%
ROA (Net income/ Total Assets) 10% 7.16% 9.58% 9.61% 9.67% 8.53% 9.07% -
Assets 1 1,963 2,205 2,892 3,087 4,416 3,635 4,409 -
Book Value Per Share 2 5.950 6.310 7.000 7.590 - 11.90 14.80 -
Cash Flow per Share 1.360 2.160 1.850 1.840 2.380 - - -
Capex 1 73 98.2 92 129 107 126 130 131
Capex / Sales 3.52% 4.94% 3.8% 5.11% 3.61% 3.71% 3.52% 3.34%
Announcement Date 3/27/20 2/16/21 2/11/22 2/9/23 2/13/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
66.02 USD
Average target price
83.57 USD
Spread / Average Target
+26.58%
Consensus
  1. Stock Market
  2. Equities
  3. BRKR Stock
  4. Financials Bruker Corporation